4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001878824-25-000002
Chief Financial Officer gave up 6,228 shares (to pay taxes)
- Chief Financial Officer acquired 19,371 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2025-11-18 | Option exercise | +6,320 | 73,891 | D | ||
| McCombe William D. Chief Financial Officer | 2025-11-18 | Shares withheld for taxes | −2,032 | $5.53 | $11,237 | 71,859 | D |
| McCombe William D. Chief Financial Officer | 2025-11-18 | Option exercise | +13,051 | 84,910 | D | ||
| McCombe William D. Chief Financial Officer | 2025-11-18 | Shares withheld for taxes | −4,196 | $5.53 | $23,204 | 80,714 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2025-11-18 | Option exercise · Restricted Stock Units | −6,320 | 63,209 | D | ||
| McCombe William D. Chief Financial Officer | 2025-11-18 | Option exercise · Restricted Stock Units | −13,051 | 174,014 | D | ||
Loading xslF345X05/form4-11212025_121127.xml…